GRI Bio, Inc. (GRI) vs Moolec Science SA (MLEC)
GRI Bio, Inc. and Moolec Science SA are both Biotechnology companies. GRI Bio, Inc. and Moolec Science SA are of similar size ($4.6M and $4.3M). Moolec Science SA has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. GRI Bio, Inc. has the higher net margin (0.00% vs −7.18%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Moolec Science SA leads on 7 and GRI Bio, Inc. on 6.
Valuation
Profitability
| Metric | GRI | MLEC | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 39.67% | 65.16% |
| Operating margin | 0.00% | 4.09% | 0.00% |
| Net margin | 0.00% | (7.18%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (142.02%) | 0.00% | (57.72%) |
| Return on assets | (113.27%) | 0.00% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack